Literature DB >> 30656815

Use of medicines that may precipitate delirium prior to hospitalisation in older Australians with delirium: An observational study.

Gizat M Kassie1, Lisa M Kalisch Ellett1, Tuan A Nguyen1, Elizabeth E Roughead1.   

Abstract

OBJECTIVE: To assess the use of medicines associated with delirium prior to hospital admission in older Australian patients with a recorded diagnosis of delirium.
METHODS: A retrospective observational study was conducted using de-identified data from the Australian Government Department of Veterans' Affairs Health Care Claims Database. The prevalence of use of medicines associated with delirium was determined in people 65 years or older with a delirium diagnosis.
RESULTS: Three-quarters of the total 22 923 older patients included were taking at least one medicine associated with delirium, the median number of medications per patient was two (interquartile range, 1-3). The most frequently used medicines known to be associated with delirium were psycholeptics, opioids and tricyclic antidepressants.
CONCLUSION: A substantial proportion of older hospitalised patients with a delirium diagnosis were taking medicines known or suspected to precipitate delirium prior to admission. There may be an opportunity to decrease medication-associated delirium by reducing use of risky medication.
© 2019 AJA Inc.

Entities:  

Keywords:  delirium; drug utilization; inappropriate prescribing; medication review; older patients

Year:  2019        PMID: 30656815     DOI: 10.1111/ajag.12608

Source DB:  PubMed          Journal:  Australas J Ageing        ISSN: 1440-6381            Impact factor:   2.111


  1 in total

1.  Hospitalizations of older people in an emergency department related to potential medication-induced hyperactive delirium: a cross-sectional study.

Authors:  Júlia Raso; Lincoln Marques Cavalcante Santos; Débora Alves Reis; Marília Amaral Costa Frangiotti; Ariane Cristina Barboza Zanetti; Helaine Carneiro Capucho; Maria Teresa Herdeiro; Fátima Roque; Leonardo Régis Leira Pereira; Fabiana Rossi Varallo
Journal:  Int J Clin Pharm       Date:  2022-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.